The European Vaccines Hub (EVH) for Pandemic Readiness convened its annual consortium meeting at the Old University of the Marburg University, in Marburg, Germany, from May 19 to 21, 2026. The EVH is a pan-European public private partnership co-funded under the EU4Health program by the European Health and Digital Executive Agency (HaDEA) on behalf of the Health Emergency Preparedness and Response Authority (DG HERA) of the European Commission. The Helmholtz Centre for Infection Research (HZI) is an affiliated entity of the initiative and leads a work package on data management and AI.

Camilla Ciolli Mattioli’s workday often begins in a place that many group leaders gradually trade for their desks over the course of their careers: the laboratory. “At the moment, I still carry out many experiments myself,” says the head of the research group “Systems Microbiology of Intracellular Pathogens,” which was launched in February at the Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with the Julius-Maximilians-Universität Würzburg (JMU). Her lab is still being set up—with her right in the middle of it. “I work closely with my team and teach my lab members the necessary procedures,” she adds.

Researchers at the Helmholtz Institute for One Health (HIOH) have demonstrated that larvae of the greater wax moth (Galleria mellonella) are suitable as an alternative infection model for investigating the pathogenicity of bacteria on a larger scale. This could significantly reduce animal testing on mammals in the future. The results of the study were published in “The Lancet Microbe”.